Bacil Pharma (BOM:524516) 3-Year EBITDA Growth Rate : 7.10% (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Bacil Pharma 3-Year EBITDA Growth Rate?

Bacil Pharma's EBITDA per Share for the three months ended in Mar. 2024 was ₹-0.12.

During the past 3 years, the average EBITDA Per Share Growth Rate was 7.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bacil Pharma was 60.30% per year. The lowest was -342.30% per year. And the median was -37.00% per year.

Competitive Comparison of Bacil Pharma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Bacil Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bacil Pharma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bacil Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bacil Pharma's 3-Year EBITDA Growth Rate falls into.

Bacil Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bacil Pharma (BOM:524516) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bacil Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bacil Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bacil Pharma (BOM:524516) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bacil Pharma Ltd (BOM:524516) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Sir P. M. Road, No. 71, Laxmi Building, 4th Floor, Fort, Mumbai, MH, IND, 400 001

Website

https://www.bacilpharma.co.in

Bacil Pharma Ltd is an Indian-based pharmaceutical company operating in a single segment. It is engaged in the manufacturing of pharmaceuticals, medicinal chemicals, and botanical products. The company manufactures, exports, supplies, and retail Anti Anxiety Medicine, Antihistamines, Chemical Compound, Drugs and Herbal Tablets, and Capsules.

Bacil Pharma (BOM:524516) Headlines

No Headlines